FDA PMA FDA Class 3 Approved 🇺🇸 United States

Kit, Dna Detection, Human Papillomavirus

PMA: P190028 · Supplement: S021 · Decision Sep 19, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Kit, Dna Detection, Human Papillomavirus
Trade Name
cobas HPV
PMA Number
P190028
Supplement Number
S021
Device Class
FDA Class 3
Product Code
MAQ
Generic Name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Medical Specialty
Unknown
Advisory Committee
Microbiology
Decision
Approved
Decision Code
APPR
Decision Date
September 19, 2025
Date Received
August 22, 2025
Supplement Type
Special (Immediate Track)
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

cobas HPV for use on the cobas 5800/6800/8800 Systems (cobas HPV) is a qualitative in vitro test for the detection of high-risk Human Papillomavirus. This test detects the high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 in the specimens listed below. Clinician-collected cervical specimens should be obtained using an endocervical brush/spatula or broom and placed in the ThinPrep Pap Test PreservCyt Solution. Self-collected vaginal specimens, obtained in a healthcare setting, can be tested as an alternative specimen type when cervical sampling is either contraindicated or cervical samples otherwise cannot be obtained. cobas HPV is indicated for use for routine cervical cancer screening as per professional medical guidelines, including triage of ASC-US cytology, co-testing (or adjunctive screen) with cytology, and HPV primary screening of individuals with a cervix to assess the risk for cervical precancer and cancer. Patients should be followed-up in accordance with professional medical guidelines, results from prior screening, medical history, and other risk factors

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAQ Kit, Dna Detection, Human Papillomavirus